Product Name |
Sitagliptin N-formyl impurity |
Alternate Names |
Sitagliptin Impurities, Impurities of Sitagliptin |
CAT No. |
CS-O-34416
|
CAS No. |
Not Available |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
435.32 g/mol |
Mol. For. |
C₁₇H₁₅F₆N₅O₂
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Sitagliptin |
Purity |
95% |
Smileys |
O=CNC(CC(N1CC2=NN=C(C(F)(F)F)N2CC1)=O)CC3=CC(F)=C(F)C=C3F |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Sitagliptin is a medication used to treat type 2 diabetes. It works by increasing the levels of certain hormones in the body that stimulate the pancreas to produce insulin and regulate blood sugar levels. Sitagliptin N-formyl impurity is a byproduct that may be present in sitagliptin formulations, and it is important to understand its chemical properties and potential effects on patients.
The N-formyl impurity is a small organic molecule with a molecular weight of around 245 grams per mole. It is formed during the manufacturing process of sitagliptin and may be present in trace amounts in the final product. While the impurity has not been extensively studied, it is believed to be relatively stable and non-reactive, and is not expected to significantly affect the efficacy or safety of sitagliptin.
However, as with any medication, it is important to closely monitor patients for adverse effects. In rare cases, the impurity could potentially cause allergic reactions or other adverse effects. Patients who experience any unusual symptoms while taking sitagliptin should consult their healthcare provider immediately.
Overall, sitagliptin N-formyl impurity is a minor byproduct that is generally considered to be safe and well-tolerated. Its presence in sitagliptin formulations is carefully controlled to ensure the safety and efficacy of the medication for patients with type 2 diabetes.